Personalized Cancer Chemotherapy
An Effective Way of Enhancing Outcomes in Clinics
- Publisher's listprice EUR 149.00
-
61 797 Ft (58 855 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 6 180 Ft off)
- Discounted price 55 618 Ft (52 970 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
61 797 Ft
Availability
cancelled
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher Elsevier Science
- Date of Publication 30 October 2018
- ISBN 9780081016220
- Binding Paperback
- No. of pages84 pages
- Size 229x152 mm
- Language English 0
Categories
Long description:
"
Personalized Cancer Chemotherapy separately describes and addresses ""individualized cancer chemotherapy"" (ICC) strategies new and old, to provide readers with new insights into their characteristics and techniques, as well as key debates and future trends in this area. The book devotes chapters to drug sensitivity testing, cancer biomarkers and bioinformatics detection, pharmacogenetics, individualized antimetastatic therapy, drug combinations, assistant chemotherapy, and cost-effectiveness considerations.
A major obstacle to controlling cancer growth and metastases in patients is the inappropriate use of anticancer and antimetastatic drugs. Researchers and clinicians are now beginning to focus on ICC also called ""personalized cancer chemotherapy"" (PCC), to improve therapeutic quality and outcomes by selecting and prescribing the most appropriate and effective drugs. Using genetic, molecular, and bioinformatics data and modern experimental techniques, known tumor genes can be detected more easily than ever before; the average speed of genetic sequencing has increased 15,000 to 50,000 times since the Human Geonme Project was completed.
This book will help readers understand the pros and cons of each individualized cancer chemotherapy strategy from different angles so as to make good judgments and predictions of drug responses and clinical outcomes.
" MoreTable of Contents:
Biography
Abstract
Preface
Contents
Introduction
Drug sensitivity testing
Individualized cancer chemotherapy by detecting cancer biomarkers
Pharmacogenetics
Individualized antimetastatic therapy
Drug combinations
Assistant chemotherapy
Cost-effectiveness of individualized cancer chemotherapy
Discussion
Conclusion
